<DOC>
	<DOCNO>NCT01959412</DOCNO>
	<brief_summary>The purpose study determine efficacy indacaterol 55µg daily ( 27.5 µg twice ) QVA149 compare 75 µg indacaterol monotherapy .</brief_summary>
	<brief_title>Crossover Study Evaluate Efficacy , Safety Tolerability Different Doses Indacaterol Patients With Persistent Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<criteria>Asthma least 6 month , use inhale corticosteroid least one month , foreced breath test less normal value general population , show immediate improvement breathe give albuterol patient smoke past 6 month currently smoke , include smoke pack cigarette day least 10 year , patient history lifethreatening asthma , patient astham attack , last 6 week , require use systemic steroid , hospitalization , ER visit , patient respiratory tract infection worsen asthma screen runin period , patient requring use asthmarelated drug trial , protocoldefined inclusion/exclusion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>wheezing , short breath , laba , inhaler</keyword>
</DOC>